These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6799386)

  • 1. Diphenoloxidases in X-linked recessive (Duchenne) muscular dystrophy.
    Demos JJ; Tuil DG; Katz PC; Berthelon MA; Dautreaux B; Premont N
    Hum Genet; 1981; 59(2):154-60. PubMed ID: 6799386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diphenoloxidases in various forms of myopathy which are transmitted by different genetic mechanisms.
    Demos JJ; Tuil DG; Katz PC
    Hum Genet; 1982; 61(3):185-9. PubMed ID: 6816716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet diphenoloxidases in progressive muscular dystrophy (P.M.D.).
    Dèmos J
    Clin Genet; 1973; 4(2):79-90. PubMed ID: 4199873
    [No Abstract]   [Full Text] [Related]  

  • 4. Absence of differences in platelet dihydroxyphenylalanine (dopa) oxidase polymorphism in health and Duchenne's muscular dystrophy.
    Pacold I; Morgan J; Cohen L
    Clin Genet; 1975; 7(5):435-41. PubMed ID: 807447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimates of conditional heterozygosity risks for young females in Duchenne muscular dystrophy.
    Passos-Bueno MR; Otto PA; Zata M
    Hum Hered; 1989; 39(4):202-11. PubMed ID: 2583732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier testing in families of isolated cases of duchenne muscular dystrophy. Creatine kinase activities in female relatives of mothers with normal CK activity.
    Nicholson GA; Lane RJ; Gardner-Medwin D; Walton JN
    J Neurol Sci; 1981 Jul; 51(1):29-42. PubMed ID: 7252519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of exercise on serum creatine kinase in carriers of Duchenne muscular dystrophy.
    Gaines RF; Pueschel SM; Sassaman EA; Driscoll JL
    J Med Genet; 1982 Feb; 19(1):4-7. PubMed ID: 7069744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enzymology and myopathy. Diagnostic and genetic value of determination of platelet diphenol-oxydase activity].
    Demos J; Berthelon M
    Arch Fr Pediatr; 1972 Oct; 29(8):793-9. PubMed ID: 4632798
    [No Abstract]   [Full Text] [Related]  

  • 10. Carrier detection in Duchenne muscular dystrophy.
    Fitzsimmons JS; McLachlan JI; Reeves WG; Marriott DW; Woolfson AM; Mayhew J
    J Med Genet; 1980 Jun; 17(3):165-9. PubMed ID: 7401126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reflections on muscular dystrophy in a Sudanese kindred.
    Salih MA; Roberts DF; Omer MI; Karrar O; Bayoumi RA
    Clin Genet; 1983 Apr; 23(4):325-8. PubMed ID: 6851225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of DNA probes in detecting carriers of Duchenne muscular dystrophy: selected case studies.
    Prior TW; Blasco PA; Dove JL; Leshner RT; Gruemer HD
    Clin Chem; 1989 Apr; 35(4):679-83. PubMed ID: 2564818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood levels of superoxide dismutase and glutathione peroxidase in Duchenne muscular dystrophy.
    Burri BJ; Chan SG; Berry AJ; Yarnell SK
    Clin Chim Acta; 1980 Aug; 105(2):249-55. PubMed ID: 7398093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity.
    Nicholson GA; Gardner-Medwin D; Pennington RJ; Walton JN
    Lancet; 1979 Mar; 1(8118):692-4. PubMed ID: 85935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy.
    Drummond LM
    Arch Dis Child; 1979 May; 54(5):362-6. PubMed ID: 475411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of creatine kinase in sera from healthy women, carriers of Duchenne muscular dystrophy and cord blood, determined by the "European" recommended method with NAC-EDTA activation.
    Moss DW; Whitaker KB; Parmar C; Heckmatt J; Wikowski J; Sewry C; Dubowitz V
    Clin Chim Acta; 1981 Oct; 116(2):209-16. PubMed ID: 6794955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of the creatine kinase test in the detection of carriers of Duchenne muscular dystrophy.
    Thompson MW; Murphy EG; McAlpine PJ
    J Pediatr; 1967 Jul; 71(1):82-93. PubMed ID: 5293863
    [No Abstract]   [Full Text] [Related]  

  • 19. Carrier detection in Duchenne muscular dystrophy.
    Nicholson GA; Gardner-Medwin D; Walton JN
    Lancet; 1979 Aug; 2(8138):367. PubMed ID: 89433
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of flanking markers in prediction for Duchenne muscular dystrophy.
    Williams H; Sarfarazi M; Brown C; Thomas N; Harper PS
    Arch Dis Child; 1986 Mar; 61(3):218-22. PubMed ID: 3457554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.